Sources | Names Used |
---|---|
CTRPv2 | JQ-1:navitoclax (2:1 mol/mol) |
PharmacoGx | JQ-1:navitoclax (2:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | ZNF783 | CTRPv2 | pan-cancer | AAC | 0.17 | 2e-06 |
mRNA | SLC35E2B | CTRPv2 | pan-cancer | AAC | 0.17 | 2e-06 |
mRNA | SYP | CTRPv2 | pan-cancer | AAC | 0.17 | 2e-06 |
mRNA | BCL2 | CTRPv2 | pan-cancer | AAC | 0.17 | 2e-06 |
mRNA | IER3IP1 | CTRPv2 | pan-cancer | AAC | 0.16 | 2e-06 |
mRNA | SNAP25 | CTRPv2 | pan-cancer | AAC | 0.17 | 2e-06 |
mRNA | PCYT1B | CTRPv2 | pan-cancer | AAC | 0.17 | 2e-06 |
mRNA | ESRRG | CTRPv2 | pan-cancer | AAC | 0.16 | 2e-06 |
mRNA | ZFP14 | CTRPv2 | pan-cancer | AAC | 0.17 | 3e-06 |
mRNA | GRM4 | CTRPv2 | pan-cancer | AAC | 0.16 | 3e-06 |